FDA Drug Application (022560) for ATELVIA by APIL

Back to FDA Applications sponsored by APIL

Application Number022560
Product Number001
FormTABLET, DELAYED RELEASE;ORAL
Dosage35MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameATELVIA
Active IngredientRISEDRONATE SODIUM

Active IngredientCount
List of drugs with Active Ingredient RISEDRONATE SODIUM4


Back to FDA Applications sponsored by APIL